Cargando…

The prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction

AIMS: Previous studies have demonstrated that moderate/severe tricuspid regurgitation (TR) is associated with adverse outcome in patients with heart failure (HF) with reduced ejection fraction. Little is known about the prevalence and prognostic value of TR in patients of stage B HF and those with s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Qing‐wen, Li, Xin‐li, Fang, Johnathan, Chen, Yan, Wu, Mei‐Zhen, Yu, Yu‐Juan, Liao, Shen‐gen, Tse, Hung‐Fat, Yiu, Kai‐Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754967/
https://www.ncbi.nlm.nih.gov/pubmed/32964655
http://dx.doi.org/10.1002/ehf2.13014
_version_ 1783626283187437568
author Ren, Qing‐wen
Li, Xin‐li
Fang, Johnathan
Chen, Yan
Wu, Mei‐Zhen
Yu, Yu‐Juan
Liao, Shen‐gen
Tse, Hung‐Fat
Yiu, Kai‐Hang
author_facet Ren, Qing‐wen
Li, Xin‐li
Fang, Johnathan
Chen, Yan
Wu, Mei‐Zhen
Yu, Yu‐Juan
Liao, Shen‐gen
Tse, Hung‐Fat
Yiu, Kai‐Hang
author_sort Ren, Qing‐wen
collection PubMed
description AIMS: Previous studies have demonstrated that moderate/severe tricuspid regurgitation (TR) is associated with adverse outcome in patients with heart failure (HF) with reduced ejection fraction. Little is known about the prevalence and prognostic value of TR in patients of stage B HF and those with stage C HF with preserved ejection fraction (HFpEF). We aimed to investigate the prevalence and prognosis of TR in patients with HFpEF. METHODS AND RESULTS: From 2013 to 2017, 2014 patients with stage B (n = 1341) or C (n = 673) HFpEF were enrolled in the study. Detailed transthoracic echocardiogram was performed, and the severity of TR was graded as no, mild, moderate, and severe. The mean age of the study population was 66.7 ± 14.1 years old, and 46% were men. Mean left ventricular ejection fraction was 62.2 ± 5.5%. The prevalence of moderate/severe TR increased from stage B to C HF (8% to 16%, respectively, P < 0.01). Older age, hyperlipidaemia, atrial fibrillation, left ventricular mass, and right ventricular systolic pressure were independently associated with moderate/severe TR (P < 0.05 for all). With a median follow‐up of 3.8 (2.9–4.7) years, 346 patients died and 234 developed HF requiring hospitalization. Kaplan–Meier curve revealed that the presence of moderate/severe TR was associated with all‐cause mortality, HF requiring hospitalization and cardiovascular death (log‐rank test P < 0.01). Multivariable analysis demonstrated that moderate (hazard ratio = 1.5; 95% confidence interval: 1.1–2.2; P < 0.05) and severe TR (hazard ratio = 2.1; 95% confidence interval: 1.3–3.3; P < 0.01) were independently associated with mortality, HF requiring hospitalization and cardiovascular death. CONCLUSIONS: The presence of moderate/severe TR is not uncommon in patients with stage B HF and stage C HFpEF. Importantly, moderate/severe TR was independently associated with mortality and HF requiring hospitalization.
format Online
Article
Text
id pubmed-7754967
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-77549672020-12-23 The prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction Ren, Qing‐wen Li, Xin‐li Fang, Johnathan Chen, Yan Wu, Mei‐Zhen Yu, Yu‐Juan Liao, Shen‐gen Tse, Hung‐Fat Yiu, Kai‐Hang ESC Heart Fail Original Research Articles AIMS: Previous studies have demonstrated that moderate/severe tricuspid regurgitation (TR) is associated with adverse outcome in patients with heart failure (HF) with reduced ejection fraction. Little is known about the prevalence and prognostic value of TR in patients of stage B HF and those with stage C HF with preserved ejection fraction (HFpEF). We aimed to investigate the prevalence and prognosis of TR in patients with HFpEF. METHODS AND RESULTS: From 2013 to 2017, 2014 patients with stage B (n = 1341) or C (n = 673) HFpEF were enrolled in the study. Detailed transthoracic echocardiogram was performed, and the severity of TR was graded as no, mild, moderate, and severe. The mean age of the study population was 66.7 ± 14.1 years old, and 46% were men. Mean left ventricular ejection fraction was 62.2 ± 5.5%. The prevalence of moderate/severe TR increased from stage B to C HF (8% to 16%, respectively, P < 0.01). Older age, hyperlipidaemia, atrial fibrillation, left ventricular mass, and right ventricular systolic pressure were independently associated with moderate/severe TR (P < 0.05 for all). With a median follow‐up of 3.8 (2.9–4.7) years, 346 patients died and 234 developed HF requiring hospitalization. Kaplan–Meier curve revealed that the presence of moderate/severe TR was associated with all‐cause mortality, HF requiring hospitalization and cardiovascular death (log‐rank test P < 0.01). Multivariable analysis demonstrated that moderate (hazard ratio = 1.5; 95% confidence interval: 1.1–2.2; P < 0.05) and severe TR (hazard ratio = 2.1; 95% confidence interval: 1.3–3.3; P < 0.01) were independently associated with mortality, HF requiring hospitalization and cardiovascular death. CONCLUSIONS: The presence of moderate/severe TR is not uncommon in patients with stage B HF and stage C HFpEF. Importantly, moderate/severe TR was independently associated with mortality and HF requiring hospitalization. John Wiley and Sons Inc. 2020-09-23 /pmc/articles/PMC7754967/ /pubmed/32964655 http://dx.doi.org/10.1002/ehf2.13014 Text en © 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research Articles
Ren, Qing‐wen
Li, Xin‐li
Fang, Johnathan
Chen, Yan
Wu, Mei‐Zhen
Yu, Yu‐Juan
Liao, Shen‐gen
Tse, Hung‐Fat
Yiu, Kai‐Hang
The prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction
title The prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction
title_full The prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction
title_fullStr The prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction
title_full_unstemmed The prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction
title_short The prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction
title_sort prevalence, predictors, and prognosis of tricuspid regurgitation in stage b and c heart failure with preserved ejection fraction
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754967/
https://www.ncbi.nlm.nih.gov/pubmed/32964655
http://dx.doi.org/10.1002/ehf2.13014
work_keys_str_mv AT renqingwen theprevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction
AT lixinli theprevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction
AT fangjohnathan theprevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction
AT chenyan theprevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction
AT wumeizhen theprevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction
AT yuyujuan theprevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction
AT liaoshengen theprevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction
AT tsehungfat theprevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction
AT yiukaihang theprevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction
AT renqingwen prevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction
AT lixinli prevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction
AT fangjohnathan prevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction
AT chenyan prevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction
AT wumeizhen prevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction
AT yuyujuan prevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction
AT liaoshengen prevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction
AT tsehungfat prevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction
AT yiukaihang prevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction